Studies Report on Latest Advances in Targeted Therapy for Breast Cancer

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, April 9, 2013 Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/studies-report-on-latest-advances-in-targeted-therapy-for-breast-cancer/" align="left"]
[divider_top]

Increased Emphasis on Clinical Research to Advance Cancer Treatment

2 comments By Media Staff   |  Tuesday, April 2, 2013 In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/increased-emphasis-on-clinical-research-to-advance-cancer-treatment/" align="left"]
[divider_top]

New Findings May Lead to Better Predictions of Breast Cancer Risk in Women with Inherited Mutations

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Thursday, March 28, 2013 A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/new-findings-may-lead-to-better-predictions-of-breast-cancer-risk-in-women-with-inherited-mutations/" align="left"]
[divider_top] [divider_top]

Cycle for Survival Raises Record Funds for Rare Cancer Research

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Monday, March 25, 2013 The indoor cycling fund-raiser, in its seventh year, has raised more than $31 million for rare cancer research at Memorial Sloan-Kettering. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/cycle-for-survival-raises-record-funds-for-rare-cancer-research/" align="left"]
[divider_top]

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Wednesday, March 20, 2013 Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/cell-based-immune-therapy-shows-promise-in-leukemia-patients/" align="left"]
[divider_top]

Meet Leukemia Expert Stephen Chung

Add a Comment By Memorial Sloan-Kettering   |  Monday, March 18, 2013 Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/meet-leukemia-expert-stephen-chung/" align="left"]
[divider_top]